Table of Contents Table of Contents
Previous Page  24 / 136 Next Page
Information
Show Menu
Previous Page 24 / 136 Next Page
Page Background

AfroCentric INTEGRATED ANNUAL REPORT 2016

22

CHAIRPERSON’S REPORT

The Group

leverages its

clinical, actuarial,

data analytics and

health intelligence

capability to identify

pockets of inefficiency

and so creates value though

negotiating fairer prices of these

items in order to make healthcare

more affordable. We want to see

more of each healthcare Rand being

spent on patients care; and improving the

effectiveness of the system will mean more

value created for members.

Medscheme is the largest manager of medical schemes

with approximately 3.7 million lives under

our management.

Dr Anna Mokgokong

INTRODUCTION

I am proud to present the AfroCentric Group’s Integrated Annual Report at the end of a year that

saw continued economic upheaval and pressure on the healthcare sector. I believe that we

weathered the storms with resilience and enjoyed healthy growth in the number of lives under

our care. In part, this is thanks to our success in securing the administration of Polmed, effective

from 1 January 2016.

The year was one of internal consolidation, with the acquisition of Pharmacy Direct (Pty)

Limited (“Pharmacy Direct”), Curasana Wholesaler (Pty) Limited (“Curasana”) and a 26%

interest in Activo Health (Pty) Limited (“Activo Health”) collectively termed the (“WAD

Acquisition”) and the Sanlam investment into ACT Healthcare Assets. Our current

positive financial standing places us in the perfect position to pursue our ambitions

for growth.

The Group is positioned as an integrated healthcare company with the expansion

of the business into new areas of healthcare management, represented by

interests in the pharmacy sector and ICT solutions for health. We hold

the number one market position in managed care and are proud of our

industry-leading expertise and our long track record as a medical scheme

administrator.

However, we continue to operate in a difficult environment. The

weakness of the Rand has impacted on the purchase price of

medicines and equipment, contributing to healthcare inflation.

Fraud, waste and abuse is a serious concern for the industry,

with fraudulent claims and over-servicing (due in part to a ‘fee

for service’ provider payment model) also increasing total

healthcare costs. We take the elimination of fraud seriously

and invested R100 million in ‘Insurance Fraud Manager’, a

fraud detection software application.

TRANSFORMATION

I am proud of AfroCentric’s status as a majority black-

owned company and of the role transformation

plays in our business. The main purpose of

transformation is not to drive value creation, but

to support the legislation that advances our

Constitution. Transformation does however

add value as diversity ignites innovation.

We believe in the importance of good

corporate citizenship and promote this

through our transformation strategy,

our CSI policy, and our ED and SED

practices.

The B-BBEE codes of

practice were revised in

2015 to address abuse,

close loopholes and

reflect a more actively

interventionist